Disposition of 146 shares by Kovelman Harry of Myomo at 3.21 subject to Rule 16b-3

MYO Stock  USD 6.21  0.10  1.58%   
About 60% of Myomo's investor base is looking to short. The analysis of overall sentiment of trading Myomo Inc stock suggests that many investors are alarmed at this time. Myomo's investing sentiment overview a quick insight into current market opportunities from investing in Myomo Inc. Many technical investors use Myomo Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Myomo Inc Officer Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 146 common stock at 3.21 of Myomo by Kovelman Harry on 1st of December 2024. This event was filed by Myomo Inc with SEC on 2024-02-05. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Myomo's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Myomo's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Myomo Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Myomo can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Myomo Fundamental Analysis

We analyze Myomo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myomo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myomo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Myomo is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Myomo Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Myomo stock to make a market-neutral strategy. Peer analysis of Myomo could also be used in its relative valuation, which is a method of valuing Myomo by comparing valuation metrics with similar companies.

Peers

Myomo Related Equities

BJDXBluejay Diagnostics   19.21   
0%
100.0%
NUWENuwellis   5.51   
0%
28.0%
SINTSINTX Technologies   2.13   
0%
11.0%
RPIDRapid Micro   0.95   
4.0%
0%
RSLSReShape Lifesciences   1.00   
5.0%
0%
VVOSVivos Therapeutics   1.30   
6.0%
0%
SSKNSTRATA Skin   1.64   
8.0%
0%
SGHTSight Sciences   2.01   
10.0%
0%
NVNOEnVVeno Medical   2.32   
12.0%
0%
BBLGBone Biologics   2.36   
12.0%
0%
IRIXIRIDEX   2.79   
14.0%
0%
TIVCTivic Health   3.85   
20.0%
0%
HSCSHeart Test   5.40   
28.0%
0%
NXLNexalin Technology   8.51   
44.0%
0%
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out Myomo Hype Analysis, Myomo Correlation and Myomo Performance.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.23)
Revenue Per Share
0.835
Quarterly Revenue Growth
0.813
Return On Assets
(0.31)
Return On Equity
(0.83)
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.